PMID: 35658024): The study showed mean weight reduction of 15.0% , 19.5% , 20.9% vs 3.1% placebo at 72 weeks The study showed up to 36% of participants achieved 25% or more weight loss with tirzepatide 15 mg Tirzepatide Once Weekly for the Treatment of Obesity in People with Type 2 Diabetes (SURMOUNT-2) , published in The Lancet (Garvey WT et al., 2023
Body condition scoring: a rapid and accurate method for assessing health status in mice
Its this commitment to the scientific process that drives our work and ensures that the research community has access to the tools they need for discovery
Carnitine for Intermittent Claudication Decreased blood flow to the legs from atherosclerosis (plaque build up) often causes an aching or cramping pain in the legs while walking or exercising
The main adverse events included headaches and skin rash
Bonfiglio MF, Traeger SM, Hulisz DT, Martin BR